<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The goal of this study was to estimate the blood brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) permeability of Ginkgolide B in <z:mpath ids='MPATH_458'>normal</z:mpath> condition and models of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> both in vivo and in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>A sensitive LC-MS/MS analytical method was developed to determinate accurately the concentration of Ginkgolide B in cell, plasma and brain tissue </plain></SENT>
<SENT sid="2" pm="."><plain>The injured rat brain microvessel endothelial cells (RBMECs) induced by Na(2)S(2)O(4) served as a <z:mp ids='MP_0005039'>hypoxia</z:mp>/reoxygenation model in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>Intracellular concentration of Ginkgolide B increased in injured cells in a concentration-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>As a model of in vivo-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion, we performed middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) in rats </plain></SENT>
<SENT sid="5" pm="."><plain>Concentration of Ginkgolide B in the brain tissues showed higher in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfused animals than that in <z:mpath ids='MPATH_458'>normal</z:mpath> rats </plain></SENT>
<SENT sid="6" pm="."><plain>To evaluate potential clinical effect of Ginkgolide B, we determined therapeutic time window in MCAO rats </plain></SENT>
<SENT sid="7" pm="."><plain>Up to i.v. administration at 2h after reperfusion of rats, Ginkgolide B could decrease infarction volume and <z:hpo ids='HP_0002181'>brain edema</z:hpo>, exerting significant protective effect in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> injury </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, Ginkgolide B could pass through <z:chebi fb="2" ids="33602">BBB</z:chebi>, especially after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury of brain, and might be therapeutically effective for <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury of human brain </plain></SENT>
</text></document>